Increases in acute hepatitis B virus infections — Kentucky, Tennessee, and West Virginia, 2006–2013

Morbidity and Mortality Weekly Report

Volumn 65, Issue 3, 2016, Pages 47-50

  Harris, Aaron M ^a   Iqbal, Kashif ^a   Schillie, Sarah ^a   Britton, James ^b   Kainer, Marion A ^c   Tressler, Stacy ^d   Vellozzi, Claudia ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b Kentucky Department for Public Health   (United States)

^c TENNESSEE DEPARTMENT OF HEALTH   (United States)

^d VIRGINIA DEPARTMENT OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE DISEASE; ADULT; CAUCASIAN; HEALTH SURVEY; HEPATITIS B; HUMAN; INCIDENCE; KENTUCKY; RISK FACTOR; STATISTICS AND NUMERICAL DATA; SUBSTANCE ABUSE; TENNESSEE; WEST VIRGINIA;

ACUTE DISEASE; ADULT; EUROPEAN CONTINENTAL ANCESTRY GROUP; HEPATITIS B; HUMANS; INCIDENCE; KENTUCKY; POPULATION SURVEILLANCE; RISK FACTORS; SUBSTANCE ABUSE, INTRAVENOUS; TENNESSEE; WEST VIRGINIA;

EID: 84959259569     PISSN: 01492195     EISSN: 1545861X     Source Type: Journal    
DOI: 10.15585/mmwr.mm6503a2     Document Type: Article

References (10)

1. Kowdley KV, Wang CC, Welch S, Roberts H, Brosgart CL. Prevalence of chronic hepatitis B among foreign-born persons living in the United States by country of origin. Hepatology 2012;56:422–33. http://dx.doi.org/10.1002/hep.24804.
2. Fattovich G, Bortolotti F, Donato F. Natural history of chronic hepatitis B: special emphasis on disease progression and prognostic factors. J Hepatol 2008;48:335–52. http://dx.doi.org/10.1016/j.jhep.2007.11.011.
3. CDC. Viral hepatitis statistics and surveillance. Surveillance for viral hepatitis—United States, 2013. Atlanta, GA: US Department of Health and Human Services; 2015. http://www.cdc.gov/hepatitis/statistics/2013surveillance/index.htm.
4. Williams WW, Lu PJ, O’Halloran A, et al. Noninfluenza vaccination coverage among adults—United States, 2013. MMWR Morb Mortal Wkly Rep 2015;64:95–102.
5. Christian WJ, Hopenhayn C, Christian A, McIntosh D, Koch A. Viral hepatitis and injection drug use in Appalachian Kentucky: a survey of rural health department clients. Public Health Rep 2010;125:121–8.
6. Zibbell JE, Iqbal K, Patel RC, et al. Increases in hepatitis C virus infection related to injection drug use among persons aged ≤30 years— Kentucky, Tennessee, Virginia, and West Virginia, 2006–2012. MMWR Morb Mortal Wkly Rep 2015;64:453–8.
7. Iqbal K, Klevens RM, Kainer MA, et al. Epidemiology of acute hepatitis B in the United States from population-based surveillance, 2006–2011. Clin Infect Dis 2015;61:584–92. http://dx.doi.org/10.1093/cid/civ332.
8. Conrad C, Bradley HM, Broz D, et al. Community outbreak of HIV infection linked to injection drug use of oxymorphone—Indiana, 2015. MMWR Morb Mortal Wkly Rep 2015;64:443–4.
9. Mast EE, Margolis HS, Fiore AE, et al. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) part 1: immunization of infants, children, and adolescents. MMWR Recomm Rep 2005;54(No. RR-16).
10. US Department of Health and Human Services. Action plan for the prevention, care, and treatment of viral hepatitis. Washington, DC: US Department of Health and Human Services; 2014. https://www.aids.gov/pdf/viral-hepatitis-action-plan.pdf.